PEPTIDES DERIVED FROM TRUNCATED SOMATOSTATIN RECEPTOR SST5TMD4 AS BIOMARKERS AND THERAPEUTIC TARGETS IN TUMOURS

The present invention relates to the use of peptides derived from the extracellular end of truncated receptor sst5TMD4 as markers in a method for the diagnosis and/or prognosis of cancer in a patient, and to a diagnostic kit or device. The present invention also relates to the use of peptides derive...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	DEL RIO MORENO, Mercedes, ALORS PEREZ, Emilia, CASTA O FUENTES, Justo P, GAHETE ORTIZ, Manuel D, LUQUE HUERTAS, Ra l
Format:	Patent
Sprache:	eng ; fre ; ger
Schlagworte:	INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING PHYSICS TESTING
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention relates to the use of peptides derived from the extracellular end of truncated receptor sst5TMD4 as markers in a method for the diagnosis and/or prognosis of cancer in a patient, and to a diagnostic kit or device. The present invention also relates to the use of peptides derived from the extracellular end of truncated receptor sst5TMD4 as therapeutic targets in cancer.